Immune modulation by antibodies and antibody receptors

Bibliography

• Wershil BK, Furuta GT. 4 Gastrointestinal mucosal immunity. J Allergy Clin Immunol 2008;121:S380-3; quiz S415
   PubMed Web of Science ®Google Scholar
• Spiekermann GM, Finn PW, Ward ES, et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med 2002;196:303-10
   PubMed Web of Science ®Google Scholar
• Fritz JH, Le Bourhis L, Magalhaes JG, Philpott DJ. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol 2008;29:41-9
   PubMed Web of Science ®Google Scholar
• Dahan S, Roth-Walter F, Arnaboldi P, et al. Epithelia: lymphocyte interactions in the gut. Immunol Rev 2007;215:243-53
   PubMed Web of Science ®Google Scholar
• McCole DF, Barrett KE. Varied role of the gut epithelium in mucosal homeostasis. Curr Opin Gastroenterol 2007;23:647-54
   PubMedGoogle Scholar
• Blumberg RS. Current concepts in mucosal immunity. II. One size fits all: nonclassical MHC molecules fulfill multiple roles in epithelial cell function. Am J Physiol 1998;274:G227-31
   Google Scholar
• Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007;7:715-25
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008;8:34-47
   PubMed Web of Science ®Google Scholar
• Burmeister WP, Gastinel LN, Simister NE, et al. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 1994;372:336-43
   PubMed Web of Science ®Google Scholar
• Zhu X, Meng G, Dickinson BL, et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 2001;166:3266-76
   PubMed Web of Science ®Google Scholar
• Anderson CL, Chaudhury C, Kim J, et al. Perspective- FcRn transports albumin: relevance to immunology and medicine. Trends Immunol 2006;27:343-8
   PubMed Web of Science ®Google Scholar
• Dickinson BL, Badizadegan K, Wu Z, et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest 1999;104:903-11
   PubMed Web of Science ®Google Scholar
• Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature 1989;337:184-7
   PubMed Web of Science ®Google Scholar
• Raghavan M, Bonagura VR, Morrison SL, Bjorkman PJ. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry 1995;34:14649-57
   PubMed Web of Science ®Google Scholar
• Claypool SM, Dickinson BL, Wagner JS, et al. Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor. Mol Biol Cell 2004;15:1746-59
   PubMed Web of Science ®Google Scholar
• Claypool SM, Dickinson BL, Yoshida M, et al. Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin. J Biol Chem 2002;277:28038-50
   PubMed Web of Science ®Google Scholar
• Yoshida M, Kobayashi K, Kuo TT, et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 2006;116:2142-51
   PubMed Web of Science ®Google Scholar
• Yoshida M, Masuda A, Kuo TT, et al. IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity. Springer Semin Immunopathol 2006;28:397-403
   PubMed Web of Science ®Google Scholar
• Abrahamson DR, Powers A, Rodewald R. Intestinal absorption of immune complexes by neonatal rats: a route of antigen transfer from mother to young. Science 1979;206:567-9
   PubMed Web of Science ®Google Scholar
• Yoshida M, Claypool SM, Wagner JS, et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 2004;20:769-83
   PubMed Web of Science ®Google Scholar
• Lencer WI, Blumberg RS. A passionate kiss, then run: exocytosis and recycling of IgG by FcRn. Trends Cell Biol 2005;15:5-9
   PubMed Web of Science ®Google Scholar
• Blumberg RS, Koss T, Story CM, et al. A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J Clin Invest 1995;95:2397-402
   PubMedGoogle Scholar
• Zhu X, Peng J, Raychowdhury R, et al. The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association. Biochem J 2002;367:703-14
   PubMedGoogle Scholar
• Zhu X, Peng J, Chen D, et al. Calnexin and ERp57 facilitate the assembly of the neonatal Fc receptor for IgG with beta 2-microglobulin in the endoplasmic reticulum. J Immunol 2005;175:967-76
   PubMedGoogle Scholar
• Iwasaki A, Kelsall BL. Mucosal immunity and inflammation. I. Mucosal dendritic cells: their specialized role in initiating T cell responses. Am J Physiol 1999;276:G1074-8
   Google Scholar
• Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008;8:435-46
   PubMed Web of Science ®Google Scholar
• Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007;25:381-418
   PubMed Web of Science ®Google Scholar
• Masuda A, Yoshida M, Shiomi H, et al. Fcgamma receptor regulation of Citrobacter rodentium infection. Infect Immun 2008;76:1728-37
   PubMed Web of Science ®Google Scholar
• Bry L, Brigl M, Brenner MB. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect Immun 2006;74:673-81
   PubMed Web of Science ®Google Scholar
• Simmons CP, Clare S, Ghaem-Maghami M, et al. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun 2003;71:5077-86
   PubMedGoogle Scholar
• Maaser C, Housley MP, Iimura M, et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun 2004;72:3315-24
   PubMed Web of Science ®Google Scholar
• Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106:255-8
   PubMed Web of Science ®Google Scholar
• Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549
   PubMed Web of Science ®Google Scholar
• Mizoguchi E, Mizoguchi A, Chiba C, et al. Antineutrophil cytoplasmic antibodies in T-cell receptor alpha-deficient mice with chronic colitis. Gastroenterology 1997;113:1828-35
   PubMedGoogle Scholar
• Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004;113:1296-306
   PubMed Web of Science ®Google Scholar
• Akilesh S, Petkova S, Sproule TJ, et al. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest 2004;113:1328-33
   PubMed Web of Science ®Google Scholar
• Li N, Zhao M, Hilario-Vargas J, et al. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest 2005;115:3440-50
   PubMed Web of Science ®Google Scholar
• Rojas R, Apodaca G. Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol 2002;3:944-55
   PubMed Web of Science ®Google Scholar
• Israel EJ, Taylor S, Wu Z, et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 1997;92:69-74
   PubMed Web of Science ®Google Scholar
• Shah U, Dickinson BL, Blumberg RS, et al. Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res 2003;53:295-301
   PubMed Web of Science ®Google Scholar
• Bitonti AJ, Dumont JA, Low SC, et al. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci USA 2004;101:9763-8
   PubMed Web of Science ®Google Scholar
• Stirling CM, Charleston B, Takamatsu H, et al. Characterization of the porcine neonatal Fc receptor-potential use for trans-epithelial protein delivery. Immunology 2005;114:542-53
   PubMed Web of Science ®Google Scholar
• Faria AM, Weiner HL. Oral tolerance and TGF-beta-producing cells. Inflamm Allergy Drug Targets 2006;5:179-90
   PubMedGoogle Scholar
• Faria AM, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol 2006;13:143-57
   PubMed Web of Science ®Google Scholar
• Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331-41
   PubMed Web of Science ®Google Scholar
• Spahn TW, Kucharzik T. Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut 2004;53:456-65
   PubMed Web of Science ®Google Scholar
• Ilan Y. Oral immune regulation toward disease-associated antigens: results of Phase I clinical trials in Crohn's disease and chronic hepatitis. Ann NY Acad Sci 2004;1029:286-98
   PubMedGoogle Scholar
• Israeli E, Safadi R, Melhem A, et al. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a Phase I clinical trial. Liver Int 2004;24:295-307
   PubMed Web of Science ®Google Scholar
• Margalit M, Israeli E, Shibolet O, et al. A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach. Am J Gastroenterol 2006;101:561-8
   PubMed Web of Science ®Google Scholar
• Safadi R, Israeli E, Papo O, et al. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins. Am J Gastroenterol 2003;98:2505-15
   PubMed Web of Science ®Google Scholar
• Ochi H, Abraham M, Ishikawa H, et al. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells. Nat Med 2006;12:627-35
   PubMed Web of Science ®Google Scholar
• Zhang X, Reddy J, Ochi H, et al. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells. Int Immunol 2006;18:495-503
   PubMedGoogle Scholar
• Ishikawa H, Ochi H, Chen ML, et al. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody. Diabetes 2007;56:2103-9
   PubMed Web of Science ®Google Scholar
• Abraham M, Karni A, Dembinsky A, et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 2008;30:21-8
   PubMed Web of Science ®Google Scholar
• Von Herrath MG, Dyrberg T, Oldstone MB. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 1996;98:1324-31
   PubMedGoogle Scholar
• Homann D, Dyrberg T, Petersen J, et al. Insulin in oral immune “tolerance”: a one-amino acid change in the B chain makes the difference. J Immunol 1999;163:1833-8
   PubMed Web of Science ®Google Scholar
• Homann D, Holz A, Bot A, et al. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 1999;11:463-72
   PubMed Web of Science ®Google Scholar
• Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 2005;28:1068-76
   PubMed Web of Science ®Google Scholar
• Larche M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005;11:S69-76
   PubMed Web of Science ®Google Scholar
• Harlan DM, Von Herrath M. Immune intervention with anti-CD3 in diabetes. Nat Med 2005;11:716-8
   PubMedGoogle Scholar
• Bresson D, Togher L, Rodrigo E, et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing tregs. J Clin Invest 2006;116:1371-81
   PubMed Web of Science ®Google Scholar
• Von Herrath MG, Coon B, Wolfe T, Chatenoud L. Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance. J Immunol 2002;168:933-41
   PubMedGoogle Scholar